Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (461-470 of 497) with videos related to

Pageof 50
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2020
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both CancersDylan M Glubb, Deborah J Thompson, Katja K H Aben, et al.
Cancer|December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Carcinogenesis|October 2, 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancerKate Lawrenson, Edwin S Iversen, Jonathan Tyrer, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
American Journal of Human Genetics|May 9, 2024
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regionsEileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, et al.
Nature Communications|March 29, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerHui Shen, Brooke L Fridley, Honglin Song, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Pageof 50

Showing results (461-470 of 497) with videos related to

Sort By:
Pageof 50
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2020
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both CancersDylan M Glubb, Deborah J Thompson, Katja K H Aben, et al.
Cancer|December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Carcinogenesis|October 2, 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancerKate Lawrenson, Edwin S Iversen, Jonathan Tyrer, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
American Journal of Human Genetics|May 9, 2024
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regionsEileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, et al.
Nature Communications|March 29, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerHui Shen, Brooke L Fridley, Honglin Song, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Pageof 50